​

argenx SE (ARGX) Stock Forecast, Price Target & Predictions

OverviewOwnershipChartTranscripts

ARGX Stock Forecast

argenx SE (ARGX) stock forecast, based on 36 Wall Street analysts, predicts a 12-month average price target of $1,133.33, with a high of $1,400.00 and a low of $861.00. This represents a 29.71% increase from the last price of $873.71.

$700 $840 $980 $1 $1 $1 High: $1400 Avg: $1133.33 Low: $861 Last Closed Price: $873.71

ARGX Stock Rating

argenx SE stock's rating consensus is Buy, based on 36 Wall Street analysts. The breakdown includes 1 Strong Buy (2.78%), 31 Buy (86.11%), 4 Hold (11.11%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 36 4 31 1 Strong Sell Sell Hold Buy Strong Buy

ARGX Price Target Upside V Benchmarks

TypeNameUpside
Stockargenx SE29.71%
SectorHealthcare Stocks 15.45%
IndustryBiotech Stocks 41.48%

Price Target Trends

1M3M12M
# Anlaysts122457
Avg Price Target$1.15K$1.16K$1.12K
Last Closing Price$873.71$873.71$873.71
Upside/Downside31.42%33.14%28.10%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Oct, 26272--11
Sep, 2612---3
Aug, 267142-124
Jul, 267153--25
Jun, 266153--24
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Oct 23, 2026Sean LaamanMorgan Stanley$1.19K$875.7635.88%36.20%
Oct 23, 2026Guggenheim$1.12K$875.7627.89%28.19%
Oct 23, 2026Collen KusyRobert W. Baird$861.00$875.76-1.69%-1.45%
Oct 23, 2026Wells Fargo$1.34K$875.7652.55%52.91%
Oct 22, 2026Alex ThompsonStifel Nicolaus$1.20K$886.4735.37%37.35%
Oct 14, 2026Wells Fargo$1.36K$802.6468.94%55.20%
Oct 12, 2026Leland GershellOppenheimer$1.04K$822.2926.23%18.80%
Oct 09, 2026Morgan Stanley$1.14K$815.8639.73%30.48%
Oct 09, 2026Evercore ISI$1.08K$817.5131.86%23.38%
Oct 09, 2026Collen KusyRobert W. Baird$823.00$818.630.53%-5.80%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Oct 23, 2026Morgan StanleyOverweightOverweighthold
Oct 23, 2026GuggenheimBuyBuyhold
Oct 22, 2026JefferiesBuyBuyhold
Oct 21, 2026CitigroupBuyBuyhold
Oct 20, 2026Cowen & Co.BuyBuyhold
Oct 20, 2026RBC CapitalOutperformOutperformhold
Oct 12, 2026OppenheimerOutperformOutperformhold
Oct 09, 2026Wells FargoOverweightOverweighthold
Oct 08, 2026H.C. WainwrightBuyBuyhold
Aug 26, 2026Wells FargoOverweightOverweighthold

Financial Forecast

EPS Forecast

$-20 $-7 $6 $19 $32 $45 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-7.99$-13.05$-5.16-----
Avg Forecast$-6.93$-13.84$-4.27$2.19$9.99$18.54$26.94$34.47
High Forecast$-6.13$-10.14$-3.65$3.24$17.75$35.69$34.50$42.05
Low Forecast$-8.38$-16.90$-6.65$0.91$3.87$7.41$13.79$24.60
Surprise %15.30%-5.71%20.84%-----

Revenue Forecast

$0 $2B $3B $5B $6B $8B Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$497.28M$410.75M$1.23B-----
Avg Forecast$510.21M$441.26M$1.21B$2.17B$3.32B$4.40B$5.38B$6.49B
High Forecast$592.33M$516.41M$1.22B$2.20B$3.80B$4.52B$5.54B$7.58B
Low Forecast$464.78M$350.58M$1.18B$2.14B$2.82B$4.28B$5.21B$5.06B
Surprise %-2.54%-6.92%1.38%-----

Net Income Forecast

$-1B $-300M $400M $1B $2B $3B Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-408.26M$-709.59M$-295.05M-----
Avg Forecast$-396.15M$-173.12M$-268.11M$118.49M$647.04M$1.30B$1.79B$1.97B
High Forecast$-350.29M$-54.70M$-84.72M$185.18M$1.01B$2.04B$1.97B$2.40B
Low Forecast$-479.04M$-291.53M$-451.51M$51.81M$221.00M$423.47M$788.32M$1.41B
Surprise %3.06%309.90%10.05%-----

ARGX Forecast FAQ

Is argenx SE stock a buy?

argenx SE stock has a consensus rating of Buy, based on 36 Wall Street analysts. The rating breakdown includes 1 Strong Buy, 31 Buy, 4 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that argenx SE is a favorable investment for most analysts.

What is argenx SE's price target?

argenx SE's price target, set by 36 Wall Street analysts, averages $1.13K over the next 12 months. The price target range spans from $861 at the low end to $1.4K at the high end, suggesting a potential 29.71% change from the previous closing price of $873.71.

How does argenx SE stock forecast compare to its benchmarks?

argenx SE's stock forecast shows a 29.71% upside, outperforming the average forecast for the healthcare stocks sector (15.45%) and underperforming the biotech stocks industry (41.48%).

What is the breakdown of analyst ratings for argenx SE over the past three months?

  • October 2026: 18.18% Strong Buy, 63.64% Buy, 18.18% Hold, 0% Sell, 0% Strong Sell.
  • September 2026: 33.33% Strong Buy, 66.67% Buy, 0% Hold, 0% Sell, 0% Strong Sell.
  • August 2026: 29.17% Strong Buy, 58.33% Buy, 8.33% Hold, 0% Sell, 4.17% Strong Sell.

What is argenx SE’s EPS forecast?

argenx SE's average annual EPS forecast for its fiscal year ending in December 2024 is $2.19, marking a -142.44% decrease from the reported $-5.16 in 2023. Estimates for the following years are $9.99 in 2025, $18.54 in 2026, $26.94 in 2027, and $34.47 in 2028.

What is argenx SE’s revenue forecast?

argenx SE's average annual revenue forecast for its fiscal year ending in December 2024 is $2.17B, reflecting a 76.93% increase from the reported $1.23B in 2023. The forecast for 2025 is $3.32B, followed by $4.4B for 2026, $5.38B for 2027, and $6.49B for 2028.

What is argenx SE’s net income forecast?

argenx SE's net income forecast for the fiscal year ending in December 2024 stands at $118.49M, representing a -140.16% decrease from the reported $-295M in 2023. Projections indicate $647.04M in 2025, $1.3B in 2026, $1.79B in 2027, and $1.97B in 2028.